Literature DB >> 11012949

The perioperative management of children with phaeochromocytoma.

H A Hack1.   

Abstract

The safe anaesthetic management of a child with a phaeochromocytoma requires an understanding of the pathophysiology of the disease, together with a thorough knowledge of its pharmacology, in order to avoid or minimize the potentially harmful cardiovascular changes that may occur during anaesthesia. Although there is a considerable amount of information on the management of the adult with phaeochromocytoma, much less has been written concerning children with the disease. Children differ significantly from adults in the incidence, location, presentation and management of this condition and these differences are discussed here together with some of the more controversial issues of management.

Entities:  

Mesh:

Year:  2000        PMID: 11012949     DOI: 10.1046/j.1460-9592.2000.00504.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  14 in total

1.  Severe intraoperative hypertension after induction of anesthesia in a child with a neuroblastoma.

Authors:  Hiromi Kako; Thomas Taghon; Giorgio Veneziano; Jennifer H Aldrink; Rose Ayoob; Joseph D Tobias
Journal:  J Anesth       Date:  2013-01-05       Impact factor: 2.078

2.  The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.

Authors:  Herbert Chen; Rebecca S Sippel; M Sue O'Dorisio; Aaron I Vinik; Ricardo V Lloyd; Karel Pacak
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 3.  Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Authors:  Amrish Jain; Rossana Baracco; Gaurav Kapur
Journal:  Pediatr Nephrol       Date:  2019-01-02       Impact factor: 3.714

4.  Functional paraganglioma.

Authors:  Gokulakrishnan Balasubramanian; Vallikantha Nellaiappan
Journal:  BMJ Case Rep       Date:  2014-02-20

5.  A sporadic case of paraganglioma undetected by urine metabolite screening.

Authors:  Detlef Bockenhauer; Lesley Rees; Hartmut Neumann; Ying Foo
Journal:  Pediatr Nephrol       Date:  2008-05-06       Impact factor: 3.714

Review 6.  Update on pediatric pheochromocytoma.

Authors:  Bas Havekes; Johannes A Romijn; Graeme Eisenhofer; Karen Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

7.  Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening?

Authors:  Tamara Prodanov; Bas Havekes; Katherine L Nathanson; Karen T Adams; Karel Pacak
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

Review 8.  Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.

Authors:  William F Young
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

9.  Treatment of Hypertension in Children With Catecholamine-Secreting Tumors: A Systematic Approach.

Authors:  Mauricio Romero; Gaurav Kapur; Rossana Baracco; Rudolph P Valentini; Tej K Mattoo; Amrish Jain
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-05-23       Impact factor: 3.738

10.  Laparoscopic cortical sparing adrenalectomy for pediatric bilateral pheochromocytoma: anesthetic management.

Authors:  Geetha Chamanhalli Rajappa; Tejesh Channasandra Anandaswamy
Journal:  Anesth Pain Med       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.